AGL 39.58 Decreased By ▼ -0.42 (-1.05%)
AIRLINK 131.22 Increased By ▲ 2.16 (1.67%)
BOP 6.81 Increased By ▲ 0.06 (0.89%)
CNERGY 4.71 Increased By ▲ 0.22 (4.9%)
DCL 8.44 Decreased By ▼ -0.11 (-1.29%)
DFML 41.47 Increased By ▲ 0.65 (1.59%)
DGKC 82.09 Increased By ▲ 1.13 (1.4%)
FCCL 33.10 Increased By ▲ 0.33 (1.01%)
FFBL 72.87 Decreased By ▼ -1.56 (-2.1%)
FFL 12.26 Increased By ▲ 0.52 (4.43%)
HUBC 110.74 Increased By ▲ 1.16 (1.06%)
HUMNL 14.51 Increased By ▲ 0.76 (5.53%)
KEL 5.19 Decreased By ▼ -0.12 (-2.26%)
KOSM 7.61 Decreased By ▼ -0.11 (-1.42%)
MLCF 38.90 Increased By ▲ 0.30 (0.78%)
NBP 64.01 Increased By ▲ 0.50 (0.79%)
OGDC 192.82 Decreased By ▼ -1.87 (-0.96%)
PAEL 25.68 Decreased By ▼ -0.03 (-0.12%)
PIBTL 7.34 Decreased By ▼ -0.05 (-0.68%)
PPL 154.07 Decreased By ▼ -1.38 (-0.89%)
PRL 25.83 Increased By ▲ 0.04 (0.16%)
PTC 17.81 Increased By ▲ 0.31 (1.77%)
SEARL 82.30 Increased By ▲ 3.65 (4.64%)
TELE 7.76 Decreased By ▼ -0.10 (-1.27%)
TOMCL 33.46 Decreased By ▼ -0.27 (-0.8%)
TPLP 8.49 Increased By ▲ 0.09 (1.07%)
TREET 16.62 Increased By ▲ 0.35 (2.15%)
TRG 57.40 Decreased By ▼ -0.82 (-1.41%)
UNITY 27.51 Increased By ▲ 0.02 (0.07%)
WTL 1.37 Decreased By ▼ -0.02 (-1.44%)
BR100 10,504 Increased By 59.3 (0.57%)
BR30 31,226 Increased By 36.9 (0.12%)
KSE100 98,080 Increased By 281.6 (0.29%)
KSE30 30,559 Increased By 78 (0.26%)

Irish food group Glanbia said on Monday it would spend $315 million to buy Optimum Nutrition, Inc, a US maker of supplements for body builders, which will use by-products of its cheese manufacturing. Privately owned Optimum makes protein powders, drinks and sports bars based on whey, which emerges as a secondary product in Glanbia's cheese plants.
"The transaction is expected to be earnings enhancing from this year," Glanbia Group Managing Director John Moloney said in a statement. Shares in Glanbia, which makes cheddar in the United States and ranks itself as Europe's biggest supplier of mozzarella cheese for pizzas, traded 5.8 percent higher by 0758 GMT at 4.6 euros. The wider Irish market was up 0.7 percent.
Analysts agreed there was scope for synergies with the acquisition. "Glanbia had nutrition science and technology; route to market and customer lists were its deficit. But this deficit has been progressively eliminated through acquisitions," Davy analyst John O'Reilly said.
"It now has routes to all market segments ... and strong customer lists," O'Reilly said in a research note. Glanbia's Moloney told Reuters it was interested in further acquisitions in the sector.
"Our first goal will be to consolidate and integrate the business," Moloney said in a telephone interview. Illinois-based Optimum, which Glanbia is buying on a debt-free basis, employs 387 people in Illinois, South Carolina and Florida and had revenue of $185 million in 2007, Glanbia said.

Copyright Reuters, 2008

Comments

Comments are closed.